venBio Partners LLC Long-Term Concentrated

CIK: 0001776382 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value ($000): $351,225 (100.0% shares, 0.0% debt)

Holdings (9)

ALXO ALX ONCOLOGY HLDGS INC 22.3%

Value ($000) $78,472 Shares 9,699,925 Est. Cost $39.31 Unrealized -72.3%

HRMY HARMONY BIOSCIENCES HLDGS IN 20.1%

Value ($000) $70,654 Shares 1,448,720 Est. Cost $36.46 Unrealized +23.5%

VTYX VENTYX BIOSCIENCES INC 17.5%

Value ($000) $61,291 Shares 5,011,536 Est. Cost $18.95 Unrealized -21.1%

PHVS PHARVARIS N V 14.5%

Value ($000) $50,862 Shares 2,301,451 Est. Cost $31.46 Unrealized -40.8%

— CINCOR PHARMA INC 11.5%

Value ($000) $40,412 Shares 2,145,035 Est. Cost $17.64 Unrealized —

— IMPEL PHARMACEUTICALS INC 7.3%

Value ($000) $25,721 Shares 2,759,791 Est. Cost $8.85 Unrealized —

— AKERO THERAPEUTICS INC 5.8%

Value ($000) $20,522 Shares 2,171,664 Est. Cost $19.15 Unrealized —

— ELEVATION ONCOLOGY INC 0.7%

Value ($000) $2,613 Shares 1,866,339 Est. Cost $13.57 Unrealized —

— VERONA PHARMA PLC 0.2%

Value ($000) $678 Shares 161,897 Est. Cost $9.65 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$78,472	22.3%	$39.31	-72.3%	COM	00166B105
HRMY	HARMONY BIOSCIENCES HLDGS IN	1,448,720	$70,654	20.1%	$36.46	+23.5%	COM	413197104
VTYX	VENTYX BIOSCIENCES INC	5,011,536	$61,291	17.5%	$18.95	-21.1%	COM	92332V107
PHVS	PHARVARIS N V	2,301,451	$50,862	14.5%	$31.46	-40.8%	COM	N69605108
—	CINCOR PHARMA INC	2,145,035	$40,412	11.5%	$17.64	—	COM	17240Y109
—	IMPEL PHARMACEUTICALS INC	2,759,791	$25,721	7.3%	$8.85	—	COM	45258K109
—	AKERO THERAPEUTICS INC	2,171,664	$20,522	5.8%	$19.15	—	COM	00973Y108
—	ELEVATION ONCOLOGY INC	1,866,339	$2,613	0.7%	$13.57	—	COM	28623U101
—	VERONA PHARMA PLC	161,897	$678	0.2%	$9.65	—	SPONSORED ADS	925050106